AA
ALBO

ALPS Advisors’s Albireo Pharma Inc ALBO Stock Holding History

ALPS Advisors’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-14,058
Closed -$304K – 1161
2022
Q4 		$304K Buy
14,058
+3,310
+31% +$70K ﹤0.01% 882
2022
Q3 		$208K Sell
10,748
-864
-7% -$17.9K ﹤0.01% 1001
2022
Q2 		$231K Sell
11,612
-8,288
-42% -$219K ﹤0.01% 974
2022
Q1 		$594K Sell
19,900
-2,407
-11% -$70.5K 0.01% 410
2021
Q4 		$520K Sell
22,307
-1,288
-5% -$34.2K 0.01% 488
2021
Q3 		$736K Sell
23,595
-1,680
-7% -$52K 0.01% 425
2021
Q2 		$889K Sell
25,275
-9,306
-27% -$303K 0.01% 416
2021
Q1 		$1.22M Buy
34,581
+256
+0.7% +$9.45K 0.01% 377
2020
Q4 		$1.29M Buy
34,325
+10,110
+42% +$368K 0.01% 362
2020
Q3 		$808K Buy
24,215
+3,783
+19% +$110K 0.01% 371
2020
Q2 		$541K Sell
20,432
-6,095
-23% -$144K 0.01% 440
2020
Q1 		$434K Buy
26,527
+771
+3% +$17K 0.01% 452
2019
Q4 		$655K Buy
25,756
+418
+2% +$8.36K 0.01% 473
2019
Q3 		$507K Buy
25,338
+148
+0.6% +$3.83K ﹤0.01% 498
2019
Q2 		$812K Sell
25,190
-3,722
-13% -$124K 0.01% 376
2019
Q1 		$931K Buy
28,912
+1,253
+5% +$33.7K 0.01% 347
2018
Q4 		$678K Buy
27,659
+6,478
+31% +$171K 0.01% 403
2018
Q3 		$698K Buy
21,181
+3,924
+23% +$128K ﹤0.01% 473
2018
Q2 		$613K Buy
+17,257
New +$559K ﹤0.01% 481

Other funds holding ALBO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

ALPS Advisors's ALBO Position: Q1 2023 in Review

ALPS Advisors sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 14,058 shares — an estimated $304K sold.

ALPS Advisors first reported a position in ALBO in Q2 2018 and held it in 19 quarters. The position peaked at $1.29M in Q4 2020. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

  • ALPS Advisors reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
  • ALPS Advisors sold 14,058 Albireo Pharma Inc shares in Q1 2023, an estimated $304K.
  • ALPS Advisors first reported a position in Albireo Pharma Inc in Q2 2018 and held it in 19 quarters.
  • ALPS Advisors's Albireo Pharma Inc position peaked at $1.29M in Q4 2020.
  • 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on ALPS Advisors's 13F filing for Q1 2023, filed 10 May 2023.